April 1, 2020 / 8:16 PM / 4 months ago

BRIEF-Ascendis Pharma Continues To Monitor And Adapt To Impact Of COVID-19

April 1 (Reuters) - Ascendis Pharma A/S:

* ASCENDIS PHARMA A/S REPORTS FULL-YEAR 2019 FINANCIAL RESULTS

* ASCENDIS PHARMA A/S - CORPORATE MILESTONES REMAIN ON TRACK FOR 2020 DESPITE CURRENT GLOBAL PANDEMIC

* ASCENDIS PHARMA A/S - CONTINUES TO MONITOR AND ADAPT TO IMPACT OF COVID-19

* ASCENDIS PHARMA A/S - ENDED 2019 WITH CASH AND CASH EQUIVALENTS OF EUR 598.1 MILLION. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below